X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (116) 116
index medicus (98) 98
hematology (87) 87
female (58) 58
male (57) 57
aged (52) 52
adult (51) 51
middle aged (50) 50
oncology (46) 46
multiple myeloma (37) 37
bortezomib (29) 29
aged, 80 and over (28) 28
treatment outcome (28) 28
multiple myeloma - drug therapy (27) 27
prognosis (21) 21
stem-cell transplantation (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (19) 19
cancer (19) 19
chemotherapy (19) 19
diagnosis (19) 19
therapy (19) 19
abridged index medicus (18) 18
hemic and lymphatic diseases (18) 18
survival (17) 17
young adult (17) 17
adolescent (16) 16
dexamethasone (16) 16
medical and health sciences (16) 16
medicin och hälsovetenskap (16) 16
multiple myeloma - mortality (16) 16
patients (16) 16
thalidomide (15) 15
lenalidomide (14) 14
leukemia (14) 14
multiple myeloma - therapy (14) 14
multiple-myeloma (14) 14
antineoplastic agents - therapeutic use (13) 13
clinical medicine (13) 13
animals (12) 12
hematology, oncology and palliative medicine (12) 12
klinisk medicin (12) 12
transplantation (12) 12
care and treatment (11) 11
bone marrow (10) 10
dexamethasone - administration & dosage (10) 10
multiple myeloma - diagnosis (10) 10
stem cell transplantation (10) 10
apoptosis (9) 9
cell biology (9) 9
efficacy (9) 9
elderly-patients (9) 9
hematologi (9) 9
melphalan (9) 9
minimal residual disease (9) 9
monoclonal antibodies (9) 9
thalidomide - administration & dosage (9) 9
acute myeloid-leukemia (8) 8
antineoplastic agents - adverse effects (8) 8
carfilzomib (8) 8
disease progression (8) 8
disease-free survival (8) 8
drug therapy (8) 8
expression (8) 8
flow cytometry (8) 8
low-dose dexamethasone (8) 8
maintenance (8) 8
medical research (8) 8
mice (8) 8
multiple myeloma - pathology (8) 8
mutation (8) 8
neoplasm staging (8) 8
recurrence (8) 8
remission induction (8) 8
research (8) 8
stem cells (8) 8
thalidomide - adverse effects (8) 8
thalidomide - analogs & derivatives (8) 8
thalidomide - therapeutic use (8) 8
analysis (7) 7
articles (7) 7
cells (7) 7
combined modality therapy (7) 7
in-vitro (7) 7
kaplan-meier estimate (7) 7
plus dexamethasone (7) 7
prospective studies (7) 7
proteasome inhibitors (7) 7
proteasome inhibitors - pharmacology (7) 7
proteins (7) 7
transplantation, autologous (7) 7
usage (7) 7
antibodies, monoclonal - therapeutic use (6) 6
antineoplastic agents - administration & dosage (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
biomarkers (6) 6
boronic acids - pharmacology (6) 6
clinical trials (6) 6
clinical trials as topic (6) 6
daratumumab (6) 6
drug resistance, neoplasm (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 12, pp. e538 - e548
Journal Article
CURRENT OPINION IN ONCOLOGY, ISSN 1040-8746, 09/2017, Volume 29, Issue 5, pp. 315 - 321
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2012, Volume 30, Issue 24, pp. 2946 - 2955
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2014, Volume 9, Issue 9, pp. e107587 - e107587
Introduction: Treatment failure in acute myeloid leukemia is probably caused by the presence of leukemia initiating cells, also referred to as leukemic stem... 
INITIATING CELLS | PROGENITOR CELLS | HETEROGENEITY | DIAGNOSIS | SIDE POPULATION | SUBPOPULATION | MARKER | RESIDUAL DISEASE DETECTION | MULTIDISCIPLINARY SCIENCES | ALDEHYDE DEHYDROGENASE-ACTIVITY | CHEMOTHERAPY | Antigens, CD34 - metabolism | Prognosis | Neoplasm Recurrence, Local - metabolism | Leukemia, Myeloid, Acute - pathology | Cell Count | Humans | Leukemia, Myeloid, Acute - metabolism | Middle Aged | Hematopoietic Stem Cells - pathology | Immunophenotyping | Hematopoietic Stem Cells - metabolism | Neoplasm Recurrence, Local - diagnosis | Neoplasm Recurrence, Local - pathology | Young Adult | Animals | Leukemia, Myeloid, Acute - diagnosis | Neoplastic Stem Cells - metabolism | Adolescent | Biomarkers | Neoplastic Stem Cells - pathology | ADP-ribosyl Cyclase 1 - metabolism | Adult | Mice | Transplantation | Stem cells | B cells | Flow cytometry | Therapy | Dehydrogenases | Severe combined immunodeficiency | Toxicity | Identification methods | Leukemia | Stem cell transplantation | Medical diagnosis | Hematopoietic stem cells | Allografts | Compartments | CD38 antigen | Bone marrow | Remission | Biocompatibility | Bioindicators | Diagnosis | CD34 antigen | Interleukin 2 receptors | Cell survival | Hematology | Review boards | Myeloid leukemia | Light scattering | Minimal residual disease | Survival | Patients | Studies | Chemotherapy | Discrimination | Aberration | Acute myeloid leukemia | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2012, Volume 30, Issue 33, pp. 4098 - 4103
Journal Article
Molecular Therapy, ISSN 1525-0016, 08/2017, Volume 25, Issue 8, pp. 1946 - 1958
Chimeric antigen receptors (CARs) can effectively redirect cytotoxic T cells toward highly expressed surface antigens on tumor cells. The low expression of... 
CAR design | multiple myeloma | off-target effects | scFV | CD38 | chimeric antigen receptor | affinity | MULTIPLE-MYELOMA | MEDICINE, RESEARCH & EXPERIMENTAL | DESIGN | ANTIBODY FRAGMENT | PERSISTENCE | MATURATION | EPITOPE | REMISSIONS | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | CAR T-CELLS | GROWTH-FACTOR | LEUKEMIA | Receptors, Antigen, T-Cell - chemistry | Humans | Antibody Affinity - immunology | Multiple Myeloma - immunology | Recombinant Fusion Proteins | Lymphocyte Activation - immunology | Multiple Myeloma - therapy | Single-Chain Antibodies - metabolism | Single-Chain Antibodies - genetics | ADP-ribosyl Cyclase 1 - immunology | Cytokines - immunology | Disease Models, Animal | T-Lymphocytes, Cytotoxic - immunology | Cytokines - metabolism | Immunotherapy, Adoptive | Receptors, Antigen, T-Cell - metabolism | Multiple Myeloma - metabolism | Protein Binding - immunology | Xenograft Model Antitumor Assays | ADP-ribosyl Cyclase 1 - chemistry | Animals | T-Lymphocytes, Cytotoxic - metabolism | ADP-ribosyl Cyclase 1 - metabolism | Mice | Single-Chain Antibodies - immunology | Cell proliferation | Medical research | Antigens | Immunoglobulins | Cytokines | Surface antigens | Tumor cells | Multiple myeloma | Antibodies | Cytotoxicity | Lymphocytes T | Hemopoiesis | Proteins | Lymphocytes | Light chains | Antigen (tumor-associated) | Light | CD38 antigen | Affinity | Cancer | Interferometry | Tumors | Original
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 09/2018, Volume 32, Issue 9, pp. 1883 - 1898
Journal Article